Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to "Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan" [<i>Kidney International Reports</i> Volume 10, Issue 4, April 2025, Pages 1063-1075].

Kidney international reportsยท2025
Same author

Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan.

Kidney international reportsยท2025
Same author

Klotho supplementation decreases blood pressure and albuminuria in mice with lupus nephritis.

European journal of pharmacologyยท2024
Same author

Precision engineered peptide targeting leukocyte extracellular traps mitigate acute kidney injury in Crush syndrome.

Biochemical and biophysical research communicationsยท2023
Same author

Klotho Supplementation Reverses Renal Dysfunction and Interstitial Fibrosis in Remnant Kidney.

Kidney & blood pressure researchยท2023
Same author

A novel I551F variant of the Na<sup>+</sup>/HCO<sub>3</sub><sup>-</sup> cotransporter NBCe1-A shows reduced cell surface expression, resulting in diminished transport activity.

American journal of physiology. Renal physiologyยท2021

Related Experiment Video

Updated: May 14, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

Calciphylaxis: diagnosis and clinical features.

Matsuhiko Hayashi1

  • 1Apheresis and Dialysis Center, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. matuhiko@z3.keio.jp

Clinical and Experimental Nephrology
|February 23, 2013
PubMed
Summary
This summary is machine-generated.

Calciphylaxis, a rare disease in dialysis patients, causes painful skin ulcers and has a high mortality rate. Diagnostic criteria are proposed to aid recognition, as the condition is often overlooked.

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Related Experiment Videos

Last Updated: May 14, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
11:30

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro

Published on: June 2, 2022

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Area of Science:

  • Nephrology
  • Dermatology
  • Pathology

Background:

  • Calciphylaxis is a rare, high-mortality disease primarily affecting dialysis patients, characterized by painful skin ulcerations.
  • Its pathogenesis remains largely unknown, with risk factors including warfarin therapy, hypoalbuminemia, and calcium-phosphate metabolism disturbances.
  • A 2009 nationwide survey in Japan indicated a prevalence of less than 1:10,000 dialysis patients annually.

Purpose of the Study:

  • To address the low familiarity of calciphylaxis among Japanese nephrologists and the likelihood of underdiagnosis.
  • To propose diagnostic criteria to facilitate the recognition of calciphylaxis.
  • To highlight the need for further research into calciphylaxis treatment efficacy.

Main Methods:

  • Nationwide survey in Japan (2009) to estimate prevalence.
  • Review of reported risk factors and current management strategies.
  • Proposal of diagnostic criteria for calciphylaxis.

Main Results:

  • Calciphylaxis prevalence in Japan is estimated below 1:10,000 dialysis patients per year.
  • Approximately 60% of Japanese nephrologists are unfamiliar with calciphylaxis, suggesting it is often overlooked.
  • No specific therapy exists; supportive care including antibiotics and wound management is crucial.

Conclusions:

  • Calciphylaxis is an under-recognized condition in Japan, necessitating improved diagnostic awareness.
  • Proposed diagnostic criteria aim to improve early identification and management.
  • Sodium thiosulfate shows potential as a treatment, warranting evaluation in large clinical trials.